资源描述:
《乳腺囊实混合性肿块超声和病理对照探究》由会员上传分享,免费在线阅读,更多相关内容在工程资料-天天文库。
1、乳腺囊实混合性肿块超声和病理对照探究[摘要]目的探讨乳腺囊实混合性肿块超声声像图特征,提高超声诊断水平。方法回顾性分析105例经病理证实的乳腺囊实性病变超声声像图。乳腺囊实性肿块分为I型(囊内实质型)、II型(分隔型)、III型(实质为主型)三种类型。结果105例病变中61例(58.1%)为良性病变,44例(41.9%)为恶性病变。61例良性病变在I、II、III型中分别为33(80.5%).12(41.4%).16(45.7%);44例恶性病变依次分别为8(19.5%),17(58.6%),19(54.3%),表明囊内实质型多为
2、良性病变,而分隔型(II型)和实质为主型(III型)多为恶性病变,其中以分隔型(II型)中的恶性病变率最高。结论乳腺囊实性病变的超声表现较为复杂,通过分型有助于提高乳腺癌诊断率。[关键词]乳腺;囊实性;彩色多普勒;超声检查[中图分类号]R737[文献标识码]A[文章编号]1674-0742(2013)06(c)-0179-02BreastMixedCysticandSolidMassesUltrasoundandPathologyResearchWANGguangshan1YuQianlQuWei2LiLanlanlShuTebi
3、aolJiangxiprovinceNanchangCityThirdHospital/DepartmentofultrasoundbreastspecialisthospitalJiangxi,Nanchang330009,China;2.JiangxiprovinceNanchangCityThirdHospital/DepartmentofPathology,hospitalJiangxibreast,Nanchang330009,China[Abstract]ObjectiveThepurposeofthisstudywa
4、stoinvestigatethesonographiccharacterofcystic-solidlesionsofthebreastandtoimproveultrasonicdiagnosisrate・MethodsThesonographicfindingsof105symptomaticcystic-solidlesionsbreastwerepathologicallyconfirmedandreviewedanalysis・Cystic-solidlesionswereclassifiedas3types:type
5、I(intracysticmass),typeII(separatedmass)andtypeIII(solidmasswithpartfluidcomponent).ResultsAccordingtothepathologicaldiagnosisof105cases,61(58・1%)werebenignand44(41.9%)weremalignant.61werebenignlesions33(80.5%)intypeIand12(41.4%)intypeII,16(45.7%)intypeIII.44malignant
6、lesionsinthethreetypeswererespectively8(19.5%),17(58.6%),19(54.3%),whichshowstumoursintypeIaremainlybenignlesionswhiletumoursintypeIIandtypeIIIaremainlymalignantlesionsandtherateof.malignantlesionsintypeIIishigherthanthatintypeIII.ConclusionBecausemixedcystic-solidson
7、ographicappearanceofthebreastiscomparativelycomplex,wethinktypingwillhelptoimprovethediagnosticrateofbreastcancer.[Keywords]Breast;Cystic-solidmass;ColorDoppler;Sonography乳腺病变中的少部分超声表现为囊实混合性肿块,单纯性囊肿没有潜在的恶性,但囊实性肿块可造成模棱两可的诊断[1-2]o为探讨乳腺囊实混合性肿块超声声像图特征,该研究收集2008年1月一2011年12
8、月经超声检查105例乳腺囊实混合性病变(JUN有病理结果),进行回顾性分析,以提髙对乳腺囊实混合性肿块的超声诊断水平。1资料与方法1.1一般资料该组105例为该院住院患者,均为女性,年龄17〜82岁,平均年龄45.3岁。1.2方法使用GEVIVID